PAP
ABVX

Persistent Asset Partners’s Abivax ABVX Stock Holding History

Persistent Asset Partners’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$325K Buy
+253
New +$29.9K 0.12% 144

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Persistent Asset Partners's ABVX Position: Q1 2026 in Review

Persistent Asset Partners reduced its Abivax (ABVX) stake by 6.5% in Q1 2026, selling an estimated $186K and leaving 22,838 shares worth $2.54M. The position accounts for 0.95% of the portfolio, ranked #24.

Persistent Asset Partners first reported a position in ABVX in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.86M in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Persistent Asset Partners held 22,838 shares of Abivax worth $2.54M as of Q1 2026.
  • Persistent Asset Partners sold 1,575 Abivax shares in Q1 2026, an estimated $186K.
  • Abivax made up 0.95% of Persistent Asset Partners's portfolio in Q1 2026, its #24 holding.
  • Persistent Asset Partners first reported a position in Abivax in Q3 2025 and has held it in 3 quarters since.
  • Persistent Asset Partners's Abivax position peaked at $3.86M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.